Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Neoplasms malignant site unspecified NEC
ADR ID BADD_A03009
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
16.16.01      Neoplasms malignant site unspecified NEC
Description Not Available
MedDRA Code 10029105
MeSH ID Not Available
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE)
Synonym
Not Available
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug Name
BADD_D00231Bendamustine hydrochloride
BADD_D00269Bexarotene
BADD_D00271Bicalutamide
BADD_D00274Bimatoprost
BADD_D00277Bisoprolol
BADD_D00280Bleomycin
BADD_D00284Bortezomib
BADD_D00285Bosentan
BADD_D00286Bosutinib
BADD_D00306Budesonide
BADD_D00318Busulfan
BADD_D00329Cabergoline
BADD_D00330Cabozantinib
BADD_D00335Calcitonin
BADD_D00337Calcitriol
BADD_D00344Canagliflozin
BADD_D00349Capecitabine
BADD_D00356Carbamazepine
BADD_D00364Carboplatin
BADD_D00367Carfilzomib
BADD_D00371Carmustine
BADD_D00376Caspofungin
BADD_D00410Celecoxib
BADD_D00414Ceritinib
BADD_D00424Cevimeline
BADD_D00425Cevimeline hydrochloride
BADD_D00429Chlorambucil
BADD_D00463Cidofovir
BADD_D00469Cinacalcet hydrochloride
BADD_D00474Cisplatin
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 14 Pages